The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Uveomeningoencephalitic Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Uveomeningoencephalitic Syndrome


High impact information on Uveomeningoencephalitic Syndrome


Chemical compound and disease context of Uveomeningoencephalitic Syndrome


Biological context of Uveomeningoencephalitic Syndrome


Anatomical context of Uveomeningoencephalitic Syndrome


Gene context of Uveomeningoencephalitic Syndrome


  1. Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo. Nordlund, J.J., Albert, D., Forget, B., Lerner, A.B. Archives of dermatology. (1980) [Pubmed]
  2. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Andrade, R.E., Muccioli, C., Farah, M.E., Nussenblatt, R.B., Belfort, R. Am. J. Ophthalmol. (2004) [Pubmed]
  3. Detection of antibodies against Borrelia burgdorferi in patients with uveitis. Isogai, E., Isogai, H., Kotake, S., Yoshikawa, K., Ichiishi, A., Kosaka, S., Sato, N., Hayashi, S., Oguma, K., Ohno, S. Am. J. Ophthalmol. (1991) [Pubmed]
  4. Intravenous methylprednisolone for aseptic meningitis in Vogt-Koyanagi-Harada syndrome. Solaro, C., Messmer Uccelli, M. Eur. Neurol. (2000) [Pubmed]
  5. Vogt-Koyanagi-Harada syndrome in a 4-year old child. Cunningham, E.T., Demetrius, R., Frieden, I.J., Emery, H.M., Irvine, A.R., Good, W.V. Am. J. Ophthalmol. (1995) [Pubmed]
  6. Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Nomura, S., Matsuzaki, T., Ozaki, Y., Yamaoka, M., Yoshimura, C., Katsura, K., Xie, G.L., Kagawa, H., Ishida, T., Fukuhara, S. Blood (1998) [Pubmed]
  7. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. Yamaki, K., Gocho, K., Hayakawa, K., Kondo, I., Sakuragi, S. J. Immunol. (2000) [Pubmed]
  8. How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome? Ikeda, K., Suzuki, S., Ichijo, M., Matsuoka, Y., Irimajiri, S. Neurology (1997) [Pubmed]
  9. Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Islam, S.M., Numaga, J., Matsuki, K., Fujino, Y., Maeda, H., Masuda, K. Invest. Ophthalmol. Vis. Sci. (1994) [Pubmed]
  10. The distribution of melanocytes in the leptomeninges of the human brain. Goldgeier, M.H., Klein, L.E., Klein-Angerer, S., Moellmann, G., Nordlund, J.J. J. Invest. Dermatol. (1984) [Pubmed]
  11. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy. Sylvestre, D.L., Disston, A.R., Bui, D.P. J. Viral Hepat. (2003) [Pubmed]
  12. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Oshima, Y., Harino, S., Hara, Y., Tano, Y. Am. J. Ophthalmol. (1996) [Pubmed]
  13. High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease. Yawata, N., Nakamura, S., Kijima, M., Ikai, N., Kanai, M., Sugita, M., Ohno, S. The British journal of ophthalmology. (1999) [Pubmed]
  14. Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Kitamura, M., Kitaichi, N., Takeuchi, M., Kitamei, H., Namba, K., Yamagishi, S.I., Iwabuchi, K., Onoé, K., Ohno, S. The British journal of ophthalmology. (2005) [Pubmed]
  15. Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis. Yukawa, E., Urano, T., Nakahara, M., Miyata, K., Matsuura, T., Taketani, F., Hara, Y., Mochizuki, M. Curr. Eye Res. (2006) [Pubmed]
  16. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease. Li, B., Yang, P., Zhou, H., Huang, X., Jin, H., Chu, L., Gao, Y., Zhu, L., Kijlstra, A. The British journal of ophthalmology. (2005) [Pubmed]
  17. Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. Miyazawa, I., Abe, T., Narikawa, K., Feng, J., Misu, T., Nakashima, I., Fujimori, J., Tamai, M., Fujihara, K., Itoyama, Y. J. Neuroimmunol. (2005) [Pubmed]
  18. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Kobayashi, H., Kokubo, T., Takahashi, M., Sato, K., Miyokawa, N., Kimura, S., Kinouchi, R., Katagiri, M. Immunogenetics (1998) [Pubmed]
  19. CSF findings and distribution of T and B lymphocytes in Vogt-Koyanagi-Harada disease. Shoji, H., Kuwasaki, N., Nakashima, K., Kaji, M., Uehara, M., Yoshioka, H. The Kurume medical journal. (1984) [Pubmed]
  20. Autoimmunity and the outer retina. Rahi, A.H., Addison, D.J. Transactions of the ophthalmological societies of the United Kingdom. (1983) [Pubmed]
  21. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Zhao, M., Jiang, Y., Abrahams, I.W. Arch. Ophthalmol. (1991) [Pubmed]
  22. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease. Kogiso, M., Tanouchi, Y., Miki, S., Mimura, Y. Jpn. J. Ophthalmol. (1992) [Pubmed]
  23. Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome. Manor, R.S., Livni, E., Cohen, S. Invest. Ophthalmol. Vis. Sci. (1979) [Pubmed]
  24. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome. Kahn, M., Pepose, J.S., Green, W.R., Miller, J., Foos, R.Y. Ophthalmology (1993) [Pubmed]
  25. Humoral immune response directed against LEDGF in patients with VKH. Yamada, K., Senju, S., Shinohara, T., Nakatsura, T., Murata, Y., Ishihara, M., Nakamura, S., Ohno, S., Negi, A., Nishimura, Y. Immunol. Lett. (2001) [Pubmed]
WikiGenes - Universities